Personalized cancer vaccine plus immunotherapy reduces melanoma recurrence after surgery

Adding a personalized mRNA-based crab vaccine to immunotherapy aft country for high-risk melanoma reduced the hazard of recurrence oregon decease by 42%, according to results from the signifier 3 INTerpath-001 proceedings presented astatine the ESMO Congress 2026. The vaccine, intismeran autogene, was fixed alongside pembrolizumab and compared with pembrolizumab alone.